World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
38283
World Ranking
1535
National Ranking
769

Medicine

D-Index
82
Citations
38704
World Ranking
15869
National Ranking
7985

John P. Phair publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John P. Phair sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 308 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John P. Phair D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John P. Phair sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John P. Phair was affiliated with Northwestern University in the United States and contributed extensively to the fields of medicine and health professions, with a particular focus on vascular surgery and related subfields. Their research coursework frequently covered the disciplines of surgery, pulmonary and respiratory medicine, general health professions, gender studies, and public health, environmental, and occupational health.

The main topics addressed in their work included diversity and career in medicine, cerebrovascular and carotid artery diseases, peripheral artery disease management, venous thromboembolism diagnosis and management, acute ischemic stroke management, diagnosis and treatment of venous diseases, and medical malpractice and liability issues.

Phair's research output featured several recent papers, notable among them:

  • "Gender disparities in academic vascular surgeons," 2020, Journal of Vascular Surgery
  • "Trends in Sex and Racial/Ethnic Diversity in Applicants to Surgery Residency and Fellowship Programs," 2020, JAMA Surgery
  • "The Effect of COVID-19 on Training and Case Volume of Vascular Surgery Trainees," 2021, Vascular and Endovascular Surgery
  • "Acute thrombotic manifestations of coronavirus disease 2019 infection: Experience at a large New York City health care system," 2020, Journal of Vascular Surgery
  • "Managing central venous access during a health care crisis," 2020, Journal of Vascular Surgery

Frequent collaborators included Issam Koleilat, Krystina Choinski, Peter L. Faries, Matthew Carnevale, and Windsor Ting, reflecting ongoing partnerships across multiple research projects. Phair published predominantly in venues tied closely to vascular surgery, with a strong presence in the Journal of Vascular Surgery and Annals of Vascular Surgery, alongside contributions to Vascular and Endovascular Surgery, Vascular, and the Journal of Vascular Surgery Cases and Innovative Techniques.

  • Journal of Vascular Surgery
  • Annals of Vascular Surgery
  • Vascular and Endovascular Surgery
  • Vascular
  • Journal of Vascular Surgery Cases and Innovative Techniques

The body of work completed by John P. Phair reflected a sustained focus on clinical and academic aspects of vascular surgery. Their contributions included examination of diversity challenges within academic surgery, impacts of the COVID-19 pandemic on surgical training, and management of acute vascular conditions in clinical settings.

Best Publications

  • A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

    Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes

  • Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection

    John W. Mellors;Alvaro Muñoz;Janis V. Giorgi;Joseph B. Margolick

  • The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

    Yaoxing Huang;William A. Paxton;Steven M. Wolinsky;Avidan U. Neumann

  • THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTS

    Kaslow Ra;Ostrow Dg;Detels R;Phair Jp

  • HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

    Chloe L Thio;Eric C Seaberg;Richard Skolasky;John Phair

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Richard A. Kaslow;Mary Carrington;R. Apple;L. Park

  • Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage

    Janis V. Giorgi;Lance E. Hultin;Jane A. McKeating;Timothy D. Johnson

  • KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

    Shou-Jiang Gao;Lawrence Kingsley;Ming Li;Wei Zheng

  • The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

    John Phair;Alvaro Muñoz;Roger Detels;Richard Kaslow

  • Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant

    Cheryl Winkler;William Modi;Michael W. Smith;George W. Nelson

  • Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection Duration

    Roger Detels;Alvaro Muñoz;Glen McFarlane;Lawrence A. Kingsley

  • Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

    Maureen P. Martin;Ying Qi;Xiaojiang Gao;Eriko Yamada

  • Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

    Shou Jiang Gao;Lawrence Kingsley;Donald R. Hoover;Thomas J. Spira

  • Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.

    Xiaojiang Gao;George W. Nelson;Peter Karacki;Maureen P. Martin

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Clinical manifestations of AIDS in the ERA of pneumocystis prophylaxis

    Donald R. Hoover;Alfred J. Saah;Helena Bacellar;John Phair

  • A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.

    Leondios G. Kostrikis;Yaoxing Huang;John P. Moore;Steve M. Wolinsky

  • Natural History of Human Immunodeficiency Virus Type 1 Viremia after Seroconversion and Proximal to AIDS in a Large Cohort of Homosexual Men

    Robert H. Lyles;Alvaro Muñoz;Traci E. Yamashita;Holly Bazmi

  • HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty

    Loic Desquilbet;Lisa P Jacobson;Linda P Fried;John P Phair

Frequent Co-Authors

Roger Detels
Roger Detels University of California, Los Angeles
Joseph B. Margolick
Joseph B. Margolick Johns Hopkins University
Lisa P. Jacobson
Lisa P. Jacobson Johns Hopkins University
Charles R. Rinaldo
Charles R. Rinaldo University of Pittsburgh
Alvaro Muñoz
Alvaro Muñoz Johns Hopkins University
Alfred J. Saah
Alfred J. Saah MSD (United States)
Stephen J. O'Brien
Stephen J. O'Brien Nova Southeastern University
Steven M. Wolinsky
Steven M. Wolinsky Northwestern University
Richard A. Kaslow
Richard A. Kaslow Yale School of Medicine
Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens diverse career opportunities, especially when paired with complementary healthcare degrees. For those interested in advanced nursing roles, exploring cheap psych np programs can be a strategic way to specialize in mental health while benefiting from affordable tuition options.

For Immunology graduates interested in clinical practice and wishing to pursue nursing leadership roles, understanding the dnp salary landscape is crucial. Salaries vary by state and specialization, making informed decisions essential for long-term career planning.

Those aiming to deepen their expertise in critical care might consider acnp programs, which provide focused training for Acute Care Nurse Practitioners. This pathway is ideal for professionals looking to transition from Family Nurse Practitioner roles into acute and critical care settings.

Additionally, accelerated learning options are available through accelerated nurse practitioner programs, allowing students to fast-track their certifications and enter the workforce sooner without compromising on quality education.

Best Scientists Citing John P. Phair

Recently Published Articles